Company Profile

Microcures Inc
Profile last edited on: 11/21/2019      CAGE: 79J36      UEI: KTD9TQGMNMR1

Business Identifier: Nanoparticle therapeutics to enhance tissue regeneration and repair: wound healing
Year Founded
2011
First Award
2017
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

105 Sylvar Street
Santa Cruz, CA 95060
   N/A
   info@microcures.com
   www.microcures.com
Location: Multiple
Congr. District: 19
County: Santa Cruz

Public Profile

With facilities and personnel in various locations on both coasts, the wound healing work in Microcures is based on the work of David Sharp, Ph.D., the firm's founder and chief scientific officer, and an expert on cell movement, Microcures has established a first-of-its-kind cell motility modulation platform that represents an innovative approach to tissue repair and disease treatment. Targeting the microtubule cytoskeleton to change the activity of microtubule regulatory proteins that control cell growth, and motility, Microcures Inc is developing nanoparticle therapeutics to enhance tissue regeneration and repair. The firm offers enhancer technology as well as inhibitor technology to promote the cellular healing process. The enhancer technology is designed to heal wounds, regenerate axon, and assist with myocardial infarction by regenerating vessels. On the other end, inhibitor technology limits fibrosis in tissues and organs, as well as suppress the movement of cancer cells.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Key People / Management

  Derek Proudian -- CEO

  Abhinav Dey

  Jeff Hanson -- Director

  Adam Hildyard Kramer -- Lead Scientist

  Hans Küpper -- Director

  Brian P O'Rourke

  David J Sharp -- Founder and CSO

  Robert Singer -- Director